The authors reply

Affiliations

¹ Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: jack.wetzels@radboudumc.nl.
² Sorbonne University, Université Pierre et Marie Curie Paris 06, and Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S1155, Paris, France.
³ The George Institute for Global Health, New Delhi, India; School of Public Health, Imperial College, London, UK; Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.

Comment

Jack F M Wetzels et al. Kidney Int. 2022 Jan.

. 2022 Jan;101(1):187.

doi: 10.1016/j.kint.2021.11.010.

¹ Department of Nephrology, Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: jack.wetzels@radboudumc.nl.
² Sorbonne University, Université Pierre et Marie Curie Paris 06, and Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S1155, Paris, France.
³ The George Institute for Global Health, New Delhi, India; School of Public Health, Imperial College, London, UK; Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.

No abstract available

Comment on

KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases.
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. Kidney Int. 2021 Oct;100(4S):S1-S276. doi: 10.1016/j.kint.2021.05.021. Kidney Int. 2021. PMID: 34556256 No abstract available.
Comments on the 2021 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for anticoagulant therapy in patients with membranous nephropathy.
Li X, Zhang X. Li X, et al. Kidney Int. 2022 Jan;101(1):186-187. doi: 10.1016/j.kint.2021.11.009. Kidney Int. 2022. PMID: 34991806 No abstract available.